No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales - Authors' reply

No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales - Authors' reply

Bibliographic Details
Main Authors:	Snape, MD, Pollard, A
Format:	Journal article
Published:	2006

Similar Items

No evidence for capsule replacement...and Wales - Authors' Reply
by: Snape, M, et al.
Published: (2006)

Meningococcal meningitis presenting postinfant group B meningococcal immunisation
by: So, N, et al.
Published: (2018)

Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood.
by: Khatami, A, et al.
Published: (2011)

Meningococcal polysaccharide-protein conjugate vaccines.
by: Snape, MD, et al.
Published: (2005)

Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccine.
by: O'Connor, D, et al.
Published: (2014)

Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccine
by: O'Connor, D, et al.
Published: (2014)

Impact of serogroup A meningococcal conjugate vaccine for Africa
by: James M. Stuart
Published: (2018-05-01)

Will booster doses be required for serogroup B meningococcal vaccine?
by: McQuaid, F, et al.
Published: (2014)

MEMORY B CELL RESPONSES FOLLOWING IMMUNISATION WITH POLYSACCHARIDE AND CONJUGATE QUADRIVALENT MENINGOCOCCAL ACYW135 VACCINES IN HEALTHY ADULT VOLUNTEERS
by: Maheshi, R, et al.
Published: (2010)

Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
by: Snape, MD, et al.
Published: (2009)

Serogroup B meningococcal vaccines-an unfinished story.
by: Sadarangani, M, et al.
Published: (2010)

Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine.
by: Snape, MD, et al.
Published: (2005)

Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.
by: Maiden, M, et al.
Published: (2008)

Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
by: Kadidja Gamougam, et al.
Published: (2015-01-01)

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine.
by: Blanchard-Rohner, G, et al.
Published: (2012)

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine
by: Blanchard-Rohner, G, et al.
Published: (2012)

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination.
by: de Whalley, P, et al.
Published: (2013)

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination
by: De Whalley, P, et al.
Published: (2013)

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil
by: Márcia de Cantuária Tauil, et al.
Published: (2014-07-01)

Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease.
by: Pollard, A, et al.
Published: (2013)

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: A community study
by: Daugla, D, et al.
Published: (2013)

CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells.
by: Kelly, D, et al.
Published: (2006)

Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.
by: Kelly, D, et al.
Published: (2009)

Meningococcal polysaccharide-protein conjugate vaccines (vol 5, pg 21, 2005)
by: Snape, MD, et al.
Published: (2005)

Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines - exploratory analyses within a randomised controlled trial
by: Khatami, A, et al.
Published: (2014)

Meningococcal disease serogroup C
by: Cuevas IE, et al.
Published: (2012-03-01)

The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012.
by: Sadarangani, M, et al.
Published: (2014)

Spontaneous point mutations in the capsule synthesis locus leading to structural and functional changes of the capsule in serogroup A meningococcal populations
by: Emma Ispasanie, et al.
Published: (2018-12-01)

Challenges and progress in the development of a serogroup B meningococcal vaccine.
by: Lewis, S, et al.
Published: (2009)

Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines--exploratory analyses within a randomised controlled trial.
by: Ameneh Khatami, et al.
Published: (2014-01-01)

Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine.
by: Mariëtte B van Ravenhorst, et al.
Published: (2018-01-01)

Seroprevalence of meningococcal serogroup C bactericidal antibodies in the Portuguese population, a decade after vaccine introduction in the National Immunisation Programme.
by: Paulo Gonçalves, et al.
Published: (2021-01-01)

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study.
by: Snape, MD, et al.
Published: (2008)

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study
by: Snape, M, et al.
Published: (2008)

Clinical recognition of meningococcal disease - Authors' reply
by: Thompson, M, et al.
Published: (2006)

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
by: Hedari CP, et al.
Published: (2014-04-01)

Erratum: Meningococcal polysaccharide-protein conjugate vaccines (Lancet Infective Diseases (2005) 5 (21-30)
by: Snape, MD, et al.
Published: (2005)

A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease.
by: Su, E, et al.
Published: (2011)

Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135.
by: Keyserling, H, et al.
Published: (2006)

Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
by: Xie, O, et al.
Published: (2013)